Michael Völker

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

TENAYA and LUCERNE

Arshad M. Khanani, Aachal Kotecha, Andrew Chang et al. · Ophthalmology · 2024 · 124 citations · Full text

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration

Sabine Aisenbrey, Focke Ziemssen, Michael Völker et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2006 · 90 citations

Ocular Disease, Ophthalmology, Age-related Diseases +6

Compound subretinal prostheses with extra-ocular parts designed for human trials: successful long-term implantation in pigs

Florian Gekeler, Peter Szurman, Salvatore Grisanti et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2006 · 75 citations

Regenerative Medicine, Vitreous Body, Ophthalmology +12

A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy

G. B. Arden, Kemal Gündüz, Anne Kurtenbach et al. · Eye · 2010 · 49 citations · Full text

Diabetic Retinopathy, Dark Adaptation, Retina +7